<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>Annals of Internal Medicine: Pulmonary Tuberculosis Topic Collection</title>
    <link>http://annals.org/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Tue, 02 Jun 2009 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 09 Apr 2013 13:47:59 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@annals.org</managingEditor>
    <webMaster>webmaster@annals.org</webMaster>
    <item>
      <title>Predictors of Extensively Drug-Resistant Pulmonary Tuberculosis</title>
      <link>http://annals.org/article.aspx?articleID=744523</link>
      <pubDate>Tue, 02 Jun 2009 00:00:00 GMT</pubDate>
      <author>Kliiman K, Altraja A. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Background:&lt;/div&gt;About 40Â 000 cases of extensively drug-resistant tuberculosis emerge worldwide annually, but the predictors of extensive drug resistance are unclear.&lt;div class="boxTitle"&gt;Objective:&lt;/div&gt;To identify risk factors for extensively drug-resistant tuberculosis and multidrug-resistant but nonâ€“extensively drug-resistant tuberculosis in patients with culture-confirmed pulmonary tuberculosis.&lt;div class="boxTitle"&gt;Design:&lt;/div&gt;Cross-sectional, countrywide study.&lt;div class="boxTitle"&gt;Setting:&lt;/div&gt;Estonia, a country with 1 of the world's highest rates of extensively drug-resistant and multidrug-resistant tuberculosis.&lt;div class="boxTitle"&gt;Patients:&lt;/div&gt;All patients with culture-confirmed pulmonary tuberculosis with clinical or radiologic evidence of active disease detected from January 2003 to December 2005.&lt;div class="boxTitle"&gt;Measurements:&lt;/div&gt;Risk determinants from patients' demographic characteristics, socioeconomic variables, and tuberculosis-related data or HIV status.&lt;div class="boxTitle"&gt;Results:&lt;/div&gt;Of 1163 patients, 60 (5.2%) had extensively drug-resistant tuberculosis and 196 (16.9%) had multidrug-resistant but nonâ€“extensively drug-resistant tuberculosis. Previous antituberculosis treatment (adjusted odds ratio [OR], 10.54 [95% CI, 5.97 to 18.62]), HIV infection (OR, 3.12 [CI, 1.31 to 7.41]), homelessness (OR, 2.73 [CI, 1.15 to 6.48]), and alcohol abuse (OR, 1.98 [CI, 1.08 to 3.64]) increased risk for extensive drug resistance. Previous treatment (OR, 4.11 [CI, 2.77 to 6.08]) and age 24 years or younger (OR, 2.57 [CI, 1.09 to 6.06]), 25 to 44 years (OR, 2.64 [CI, 1.35 to 5.16]), and 45 to 64 years (OR, 2.06 [CI, 1.06 to 3.99]) were determinants of multidrug resistance. In patients age 24 years or younger, female sex (OR, 6.23 [CI, 1.02 to 37.99]) and birth outside of Estonia (OR, 82.04 [CI, 3.46 to 1945.47]) increased risk for multidrug resistance.&lt;div class="boxTitle"&gt;Limitation:&lt;/div&gt;patients' comorbid conditions and drug abuse history were not incorporated into analyses because of inconsistent source data.&lt;div class="boxTitle"&gt;Conclusion:&lt;/div&gt;Previous treatment is a common risk factor for extensively drug-resistant and multidrug-resistant tuberculosis. Reducing relapses; screening persons younger than 65 years and immigrants; and combating against HIV infection, alcoholism, and homelessness are key issues for decreasing the spread of highly drug-resistant tuberculosis.&lt;div class="boxTitle"&gt;Primary Funding Source:&lt;/div&gt;Estonian Health Insurance Fund.&lt;/span&gt;</description>
      <guid>http://annals.org/article.aspx?articleID=744523</guid>
    </item>
  </channel>
</rss>